Last 47 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 125.47 | 278.06 | — | 20.01 | 80.44 | — | — | 36.13 | — | — | — | 34.24 | — | — | — | 54.88 | — | — | — | 109.17 | — |
| — | — | — | -44.6% | — | — | — | +5.5% | — | — | — | -37.6% | — | — | — | -49.7% | — | — | — | +253.5% | — | |
| P/S Ratio | 7.42 | 7.31 | 5.97 | 5.04 | 6.05 | 8.47 | 10.58 | 9.51 | 8.95 | 10.60 | 12.21 | 6.92 | 8.76 | 9.73 | 8.47 | 6.15 | 7.10 | 8.01 | 12.45 | 10.31 | 16.50 |
| — | -13.7% | -43.6% | -46.9% | -32.4% | -20.1% | -13.3% | +37.4% | +2.2% | +9.0% | +44.2% | +12.5% | +23.4% | +21.5% | -32.0% | -40.4% | -57.0% | -48.0% | -32.6% | +25.6% | +142.8% | |
| P/B Ratio | 5.90 | 6.12 | 4.59 | 5.29 | 5.08 | 6.99 | 7.54 | 9.82 | 8.05 | 9.19 | 10.71 | 7.96 | 7.81 | 8.98 | 7.16 | 6.74 | 6.16 | 6.79 | 10.41 | 11.51 | 14.53 |
| — | -12.3% | -39.2% | -46.2% | -37.0% | -24.0% | -29.6% | +23.3% | +3.1% | +2.3% | +49.5% | +18.1% | +27.0% | +32.4% | -31.2% | -41.5% | -57.6% | -57.9% | -42.9% | +4.1% | +89.9% | |
| P/FCF | 82.85 | 39.72 | 27.00 | 584.50 | 20.99 | 23.89 | — | 84.77 | 12.66 | 314.78 | — | 199.77 | 665.50 | 74.47 | — | 55.39 | 101.66 | 255.25 | 1160.06 | 51.32 | 486.22 |
| — | +66.3% | — | +589.5% | +65.9% | -92.4% | — | -57.6% | -98.1% | +322.7% | — | +260.7% | +554.7% | -70.8% | — | +7.9% | -79.1% | +11.1% | +1306.6% | +41.9% | +831.7% | |
| EV / EBITDA | 91.43 | 150.83 | — | 18.24 | 63.78 | 678.29 | — | 36.22 | — | — | — | 32.74 | — | — | — | 45.36 | — | — | — | 98.78 | — |
| — | -77.8% | — | -49.7% | — | — | — | +10.6% | — | — | — | -27.8% | — | — | — | -54.1% | — | — | — | +241.9% | — | |
| EV / EBIT | 185.49 | 236.93 | — | 19.30 | 77.94 | — | — | 35.94 | — | — | — | 31.89 | — | — | — | 47.21 | — | — | — | 115.49 | — |
| — | — | — | -46.3% | — | — | — | +12.7% | — | — | — | -32.4% | — | — | — | -59.1% | — | — | — | +280.7% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 74.4% | 72.8% | 72.0% | 78.7% | 73.5% | 73.7% | 69.0% | 77.6% | 71.9% | 69.5% | 68.9% | 74.6% | 67.2% | 65.2% | 64.7% | 72.6% | 65.5% | 61.7% | 65.0% | 71.5% | 64.0% |
| — | -1.2% | +4.4% | +1.4% | +2.1% | +6.1% | +0.0% | +4.0% | +7.1% | +6.6% | +6.6% | +2.8% | +2.6% | +5.7% | -0.5% | +1.5% | +2.2% | -9.4% | -2.2% | -3.9% | -8.1% | |
| Operating Margin | 4.0% | 0.6% | -11.8% | 24.1% | 5.1% | -3.2% | -24.3% | 24.5% | -4.3% | -11.5% | -10.7% | 19.6% | -11.1% | -13.0% | -19.9% | 11.5% | -17.6% | -24.5% | -20.2% | 8.7% | -14.4% |
| — | +117.5% | +51.5% | -1.6% | +220.1% | +72.0% | -128.3% | +25.2% | +61.6% | +11.8% | +46.6% | +69.6% | +37.0% | +47.1% | +1.1% | +32.7% | -22.5% | -159.8% | -110.9% | -68.0% | -231.9% | |
| Net Margin | 6.0% | 2.8% | -9.2% | 25.0% | 7.5% | -0.9% | -21.4% | 26.3% | -1.6% | -8.9% | -7.5% | 20.0% | -8.0% | -10.9% | -18.3% | 11.2% | -17.1% | -24.2% | -19.7% | 9.5% | -14.3% |
| — | +425.7% | +56.9% | -4.8% | +583.1% | +90.2% | -183.9% | +31.5% | +80.6% | +18.7% | +58.8% | +77.9% | +52.9% | +54.8% | +7.0% | +18.0% | -19.4% | -152.5% | -106.6% | -64.7% | -227.4% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 5.1% | 0.6% | -1.8% | 6.9% | 1.6% | -0.2% | -3.8% | 7.2% | -0.4% | -2.0% | -1.7% | 6.0% | -1.8% | -2.6% | -3.9% | 3.2% | -3.7% | -5.2% | -4.1% | 2.8% | -3.2% |
| — | +430.9% | +53.7% | -4.7% | +548.3% | +90.6% | -127.9% | +19.4% | +80.2% | +23.2% | +56.7% | +88.7% | +51.3% | +50.5% | +6.2% | +15.5% | -16.4% | -98.6% | -72.5% | -71.8% | -198.4% | |
| ROA | 3.6% | 0.4% | -1.3% | 4.9% | 1.1% | -0.1% | -2.6% | 4.8% | -0.2% | -1.3% | -1.1% | 3.9% | -1.2% | -1.7% | -2.8% | 2.3% | -2.7% | -3.7% | -2.9% | 1.9% | -2.2% |
| — | +447.0% | +50.7% | +2.6% | +586.0% | +89.9% | -141.3% | +24.4% | +79.8% | +26.8% | +61.0% | +70.2% | +56.4% | +52.8% | +4.9% | +17.3% | -20.7% | -111.5% | -85.8% | -71.2% | -192.9% | |
| ROIC | 2.5% | 0.1% | -1.7% | 5.0% | 0.8% | -0.5% | -3.0% | 4.5% | -0.6% | -1.7% | -1.6% | 4.0% | -1.6% | -2.1% | -3.3% | 2.6% | -3.1% | -4.1% | -3.4% | 2.0% | -2.4% |
| — | +120.4% | +42.1% | +11.4% | +227.8% | +71.7% | -83.8% | +11.4% | +61.3% | +22.2% | +50.9% | +54.3% | +47.9% | +47.7% | +2.7% | +28.4% | -27.0% | -108.8% | -99.4% | -72.1% | -182.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.28 | 0.25 | 0.27 | 0.28 | 0.30 | 0.33 | 0.33 | 0.34 | 0.38 | 0.39 | 0.39 | 0.39 | 0.42 | 0.42 | 0.24 | 0.25 | 0.27 | 0.28 | 0.29 | 0.29 | 0.32 |
| — | -23.1% | -20.8% | -18.2% | -19.6% | -17.3% | -15.1% | -13.1% | -9.1% | -6.1% | +63.4% | +57.5% | +53.8% | +52.0% | -15.4% | -16.0% | -16.6% | -19.4% | -23.7% | -25.8% | +34.2% | |
| Debt / EBITDA | 4.39 | 25.00 | — | 3.83 | 15.33 | 125.17 | — | 4.95 | — | — | — | 6.34 | — | — | — | 6.68 | — | — | — | 10.20 | — |
| — | -80.0% | — | -22.8% | — | — | — | -21.9% | — | — | — | -5.0% | — | — | — | -34.5% | — | — | — | +149.2% | — | |
| Current Ratio | 5.03 | 5.04 | 5.18 | 5.03 | 4.87 | 4.97 | 5.01 | 4.23 | 4.61 | 4.50 | 5.20 | 4.49 | 5.18 | 5.14 | 6.17 | 4.99 | 6.16 | 6.20 | 6.99 | 6.08 | 7.70 |
| — | +1.3% | +3.3% | +19.0% | +5.7% | +10.5% | -3.7% | -5.9% | -11.0% | -12.4% | -15.8% | -9.9% | -15.9% | -17.2% | -11.7% | -18.0% | -20.0% | +6.8% | +27.6% | +10.7% | +30.9% | |
| Quick Ratio | 4.68 | 4.69 | 4.79 | 4.68 | 4.47 | 4.56 | 4.58 | 3.89 | 4.23 | 4.16 | 4.83 | 4.21 | 4.83 | 4.75 | 5.64 | 4.56 | 5.54 | 5.56 | 6.33 | 5.57 | 7.00 |
| — | +2.7% | +4.6% | +20.4% | +5.8% | +9.7% | -5.3% | -7.7% | -12.5% | -12.3% | -14.4% | -7.7% | -12.9% | -14.7% | -10.9% | -18.1% | -20.9% | +5.7% | +25.7% | +9.6% | +29.5% | |
| Interest Coverage | 12.17 | 14.72 | -38.39 | 149.78 | 33.11 | -2.52 | -72.50 | 130.58 | -4.85 | -29.60 | -24.24 | 91.34 | -25.31 | -32.69 | -50.69 | 30.70 | -61.44 | -447.15 | -392.94 | 4209.00 | -4930.00 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying VCEL stock.
Vericel Corporation's current P/E is 125.5x. The average P/E over the last 3 quarters is 126.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Vericel Corporation's current operating margin is 4.0%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Vericel Corporation's business trajectory between earnings reports.